Security key
98978N101
Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO)
CUSIP: 98978N101
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $.001 per share
- Total 13F shares
- 34,250
- Total 13F value
- $82,885
- Share change
- -3,916
- SEC-reported price per share
- $2.42
- Number of holders
- 2
- Value change
- -$11,570
- Number of buys
- 1
- Number of sells
- 1
- Shares outstanding
- 3,908,612
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
2
Top holders
2
ZIVO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Zivo Bioscience, Inc. SEC filings
Zivo Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98978N101
Recent filing periods:
Ownership snapshot
Top reported holders of ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Column Capital Advisors, LLC
Disclosed value leader
GEODE CAPITAL MANAGEMENT,...
Comparable rows
1/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 0.31%
14 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Column Capital Advisors, LLC leads the comparable SEC ownership view at 0.31%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Column Capital Advisors, LLC's linked filing trail.
Comparable ownership
Top 1
Column Capital Advisors, LLC
0.31%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Column Capital Advisors, LLC |
13F
Company
|
0.31%
|
$36,960
12,000 shares
|
— | 31 Mar 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$846,466
276,623 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$336,764
109,339 shares
|
— | 31 Mar 2023 |
| Warberg Asset Management LLC |
13F
Company
|
—
class O/S missing
|
$65,346
112,163 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$48,107
15,619 shares
|
— | 31 Mar 2023 |
| Verdence Capital Advisors LLC |
13F
Company
|
—
mixed-class rows
|
$36,626
20,000 shares
mixed-class rows
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
34,250
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
1
Q2 2023 holders
2
Holder diff
1
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend